Response assessment in neuro-oncology (a report of the RANO group): assessment 
of outcome in trials of diffuse low-grade gliomas

van den Bent, M. J.; Wefel, J. S.; Schiff, D.; Taphoorn, M. J. B.; Jaeckle, K.; Junck, L.; Armstrong, T.; Choucair, A.; Waldman, A. D.; Gorlia, T.; Chamberlain, M.; Baumert, B. G.; Vogelbaum, M. A.; Macdonald, D. R.; Reardon, D. A.; Wen, P. Y.; Chang, S. M.; Jacobs, Andreas H.

doi:10.1016/S1470-2045(11)70057-2

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

MPS-Authors

/persons/resource/persons147201

Jacobs, Andreas H.
Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

van den Bent, M. J., Wefel, J. S., Schiff, D., Taphoorn, M. J. B., Jaeckle, K., Junck, L., et al. (2011). Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet-Oncology, 12(6), 583-593. doi:10.1016/S1470-2045(11)70057-2.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D8C8-7